Your session is about to expire
← Back to Search
Project Calm for Anxiety
Study Summary
This trial is testing a digital intervention for mental health in Ukrainian children and adolescents. The intervention teaches techniques that have been proven effective in helping American children calm themselves and regulate their emotions. Participants will be given
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Do I meet the necessary criteria to participate in this clinical research study?
"To be eligible for participation in this clinical trial, individuals must have a diagnosis of depression and fall within the age range of 9 to 18. The study aims to enroll approximately 1765 participants."
Are participants currently being recruited for this clinical trial?
"As per the information on clinicaltrials.gov, this specific study is currently not in the active recruitment phase. The trial was initially posted on January 16th, 2024 and last modified on January 12th, 2024. However, it is worth noting that there are currently a total of 1506 other trials actively enrolling participants at present."
What is the primary objective of this medical study?
"The primary outcome of this clinical trial, assessed immediately after the intervention, aims to measure the change in behavior and feelings using the Internalizing Subscale of the Behavior and Feelings Survey. Secondary outcomes include evaluating life satisfaction through the Peabody Treatment Progress Battery's Life Satisfaction Scale, assessing treatment expectations before the intervention with a 4-item measure on a 0-10 scale, and examining trauma symptoms at all time points using the Short Post-Traumatic Stress Disorder Rating Interview (SPRINT-10) where items are rated from 0 (not at all) to 4 (very much)."
Are individuals above the age of 60 eligible to participate in this clinical trial?
"To be eligible for this clinical trial, individuals must fall within the age range of 9 to 18 years."
Share this study with friends
Copy Link
Messenger